North America and Europe Microbiome Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2023
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
Scope of the Report:
This report focuses on the Microbiome Therapeutics in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Microbiome Therapeutics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Microbiome Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Microbiome Therapeutics, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;
Chapter 14, Microbiome Therapeutics market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers, etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.
Scope of the Report:
This report focuses on the Microbiome Therapeutics in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
- Seres Therapeutics
- Assembly Biosciences
- Synthetic Biologics
- Interxon
- PureTech
- Synlogic
- Enterome BioScience
- 4D Pharma
- Second Genome
- AOBiome
- C3 Jian
- Rebiotix
- MicroBiome Therapeutics LLC
- Metabiomics
- Ritter Pharmaceuticals
- Symberix
- OpenBiome
- Azitra
- Symbiotix Biotherapies
- Osel
- Metabogen
- United States
- United Kingdom
- Canada
- Germany
- France
- Italy
- Spain
- C. difficile Infection (CDI)
- Inflammatory Bowel Disease (IBD)
- Orphan Drug
- Immuno-oncology
- Others
Chapter 1, to describe Microbiome Therapeutics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Microbiome Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Microbiome Therapeutics, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;
Chapter 14, Microbiome Therapeutics market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers, etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.
1 MARKET OVERVIEW
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 C. difficile Infection (CDI)
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Orphan Drug
1.3.4 Immuno-oncology
1.3.5 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.2 Microbiome Therapeutics Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.2 Microbiome Therapeutics Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Interxon
2.4.1 Business Overview
2.4.2 Microbiome Therapeutics Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 PureTech
2.5.1 Business Overview
2.5.2 Microbiome Therapeutics Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Synlogic
2.6.1 Business Overview
2.6.2 Microbiome Therapeutics Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.2 Microbiome Therapeutics Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 4D Pharma
2.8.1 Business Overview
2.8.2 Microbiome Therapeutics Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Second Genome
2.9.1 Business Overview
2.9.2 Microbiome Therapeutics Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AOBiome
2.10.1 Business Overview
2.10.2 Microbiome Therapeutics Type and Applications
2.10.2.1 Type
2.10.2.2 Type
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 Microbiome Therapeutics Type and Applications
2.11.2.1 Type
2.11.2.2 Type
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Microbiome Therapeutics Type and Applications
2.12.2.1 Type
2.12.2.2 Type
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 Microbiome Therapeutics Type and Applications
2.13.2.1 Type
2.13.2.2 Type
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Microbiome Therapeutics Type and Applications
2.14.2.1 Type
2.14.2.2 Type
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Microbiome Therapeutics Type and Applications
2.15.2.1 Type
2.15.2.2 Type
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Microbiome Therapeutics Type and Applications
2.16.2.1 Type
2.16.2.2 Type
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 Microbiome Therapeutics Type and Applications
2.17.2.1 Type
2.17.2.2 Type
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Microbiome Therapeutics Type and Applications
2.18.2.1 Type
2.18.2.2 Type
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Microbiome Therapeutics Type and Applications
2.19.2.1 Type
2.19.2.2 Type
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Osel
2.20.1 Business Overview
2.20.2 Microbiome Therapeutics Type and Applications
2.20.2.1 Type
2.20.2.2 Type
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Metabogen
2.21.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.21.2.1 Type
2.21.2.2 Type
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 NORTH AMERICA AND EUROPE MICROBIOME THERAPEUTICS MARKET COMPETITION, BY MANUFACTURER
3.1 North America and Europe Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Microbiome Therapeutics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 NORTH AMERICA AND EUROPE MICROBIOME THERAPEUTICS MARKET ANALYSIS BY COUNTRIES/REGIONS
4.1 North America and Europe Microbiome Therapeutics Sales Market Share by Countries/Regions
4.2 North America and Europe Microbiome Therapeutics Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Microbiome Therapeutics Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Microbiome Therapeutics Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
5 NORTH AMERICA AND EUROPE MARKET SEGMENTATION MICROBIOME THERAPEUTICS BY TYPE
5.1 North America and Europe Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
6 NORTH AMERICA AND EUROPE MARKET SEGMENTATION MICROBIOME THERAPEUTICS BY APPLICATION
6.1 North America and Europe Microbiome Therapeutics Sales Market Share by Application (2013-2018)
6.2 C. difficile Infection (CDI) Sales Growth (2013-2018)
6.3 Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
6.4 Orphan Drug Sales Growth (2013-2018)
6.5 Immuno-oncology Sales Growth (2013-2018)
6.6 Others Sales Growth (2013-2018)
7 UNITED STATES MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 United States Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
7.2.1 United States Microbiome Therapeutics Sales by Type (2013-2018)
7.2.2 United States Microbiome Therapeutics Sales Market Share by Type (2013-2018)
7.3 United States Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
7.3.1 United States Microbiome Therapeutics Sales by Application (2013-2018)
7.3.2 United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
7.4 United States Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Microbiome Therapeutics Export and Import (2013-2018)
8 UNITED KINGDOM MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 United Kingdom Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Microbiome Therapeutics Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Microbiome Therapeutics Sales by Type (2013-2018)
8.2.2 United Kingdom Microbiome Therapeutics Sales Market Share by Type (2013-2018)
8.3 United Kingdom Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Microbiome Therapeutics Sales by Application (2013-2018)
8.3.2 United Kingdom Microbiome Therapeutics Sales Market Share by Application (2013-2018)
8.4 United Kingdom Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Microbiome Therapeutics Export and Import (2013-2018)
9 CANADA MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 Canada Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
9.2.1 Canada Microbiome Therapeutics Sales by Type (2013-2018)
9.2.2 Canada Microbiome Therapeutics Sales Market Share by Type (2013-2018)
9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"
9.3.1 Canada Microbiome Therapeutics Sales by Application (2013-2018)
9.3.2 Canada Microbiome Therapeutics Sales Market Share by Application (2013-2018)
9.4 Canada Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Microbiome Therapeutics Export and Import (2013-2018)
10 GERMANY MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
10.1 Germany Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
10.2.1 Germany Microbiome Therapeutics Sales by Type (2013-2018)
10.2.2 Germany Microbiome Therapeutics Sales Market Share by Type (2013-2018)
10.3 Germany Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
10.3.1 Germany Microbiome Therapeutics Sales by Application (2013-2018)
10.3.2 Germany Microbiome Therapeutics Sales Market Share by Application (2013-2018)
10.4 Germany Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Microbiome Therapeutics Export and Import (2013-2018)
11 FRANCE MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
11.1 France Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
11.2 France Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
11.2.1 France Microbiome Therapeutics Sales by Type (2013-2018)
11.2.2 France Microbiome Therapeutics Sales Market Share by Type (2013-2018)
11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"
11.3.1 France Microbiome Therapeutics Sales by Application (2013-2018)
11.3.2 France Microbiome Therapeutics Sales Market Share by Application (2013-2018)
11.4 France Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Microbiome Therapeutics Revenue and Market Share by Manufacturer
11.5 France Microbiome Therapeutics Export and Import (2013-2018)
12 ITALY MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
12.1 Italy Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
12.2.1 Italy Microbiome Therapeutics Sales by Type (2013-2018)
12.2.2 Italy Microbiome Therapeutics Sales Market Share by Type (2013-2018)
12.3 Italy Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
12.3.1 Italy Microbiome Therapeutics Sales by Application (2013-2018)
12.3.2 Italy Microbiome Therapeutics Sales Market Share by Application (2013-2018)
12.4 Italy Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Microbiome Therapeutics Export and Import (2013-2018)
13 SPAIN MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
13.1 Spain Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
13.2.1 Spain Microbiome Therapeutics Sales by Type (2013-2018)
13.2.2 Spain Microbiome Therapeutics Sales Market Share by Type (2013-2018)
13.3 Spain Microbiome Therapeutics Sales by Application (2013-2018)
13.3.1 Spain Microbiome Therapeutics Sales by Application (2013-2018)
13.3.2 Spain Microbiome Therapeutics Sales Market Share by Application (2013-2018)
13.4 Spain Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Microbiome Therapeutics Export and Import (2013-2018)
14 MICROBIOME THERAPEUTICS MARKET FORECAST (2018-2023)
14.1 North America and Europe Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
14.2 Microbiome Therapeutics Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Microbiome Therapeutics Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
14.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Microbiome Therapeutics Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
15 MICROBIOME THERAPEUTICS MANUFACTURING COST ANALYSIS
15.1 Microbiome Therapeutics Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Microbiome Therapeutics
16 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
16.1 Microbiome Therapeutics Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
16.4 Downstream Buyers
17 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 RESEARCH FINDINGS AND CONCLUSION
19 APPENDIX
19.1 Methodology
19.2 Data Source
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 C. difficile Infection (CDI)
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Orphan Drug
1.3.4 Immuno-oncology
1.3.5 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.2 Microbiome Therapeutics Type and Applications
2.1.2.1 Type
2.1.2.2 Type
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.2.2.1 Type
2.2.2.2 Type
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.2 Microbiome Therapeutics Type and Applications
2.3.2.1 Type
2.3.2.2 Type
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Interxon
2.4.1 Business Overview
2.4.2 Microbiome Therapeutics Type and Applications
2.4.2.1 Type
2.4.2.2 Type
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 PureTech
2.5.1 Business Overview
2.5.2 Microbiome Therapeutics Type and Applications
2.5.2.1 Type
2.5.2.2 Type
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Synlogic
2.6.1 Business Overview
2.6.2 Microbiome Therapeutics Type and Applications
2.6.2.1 Type
2.6.2.2 Type
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.2 Microbiome Therapeutics Type and Applications
2.7.2.1 Type
2.7.2.2 Type
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 4D Pharma
2.8.1 Business Overview
2.8.2 Microbiome Therapeutics Type and Applications
2.8.2.1 Type
2.8.2.2 Type
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Second Genome
2.9.1 Business Overview
2.9.2 Microbiome Therapeutics Type and Applications
2.9.2.1 Type
2.9.2.2 Type
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AOBiome
2.10.1 Business Overview
2.10.2 Microbiome Therapeutics Type and Applications
2.10.2.1 Type
2.10.2.2 Type
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 Microbiome Therapeutics Type and Applications
2.11.2.1 Type
2.11.2.2 Type
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Microbiome Therapeutics Type and Applications
2.12.2.1 Type
2.12.2.2 Type
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 Microbiome Therapeutics Type and Applications
2.13.2.1 Type
2.13.2.2 Type
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Microbiome Therapeutics Type and Applications
2.14.2.1 Type
2.14.2.2 Type
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Microbiome Therapeutics Type and Applications
2.15.2.1 Type
2.15.2.2 Type
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Microbiome Therapeutics Type and Applications
2.16.2.1 Type
2.16.2.2 Type
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 Microbiome Therapeutics Type and Applications
2.17.2.1 Type
2.17.2.2 Type
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Microbiome Therapeutics Type and Applications
2.18.2.1 Type
2.18.2.2 Type
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Microbiome Therapeutics Type and Applications
2.19.2.1 Type
2.19.2.2 Type
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Osel
2.20.1 Business Overview
2.20.2 Microbiome Therapeutics Type and Applications
2.20.2.1 Type
2.20.2.2 Type
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Metabogen
2.21.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.21.2.1 Type
2.21.2.2 Type
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 NORTH AMERICA AND EUROPE MICROBIOME THERAPEUTICS MARKET COMPETITION, BY MANUFACTURER
3.1 North America and Europe Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Microbiome Therapeutics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 NORTH AMERICA AND EUROPE MICROBIOME THERAPEUTICS MARKET ANALYSIS BY COUNTRIES/REGIONS
4.1 North America and Europe Microbiome Therapeutics Sales Market Share by Countries/Regions
4.2 North America and Europe Microbiome Therapeutics Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Microbiome Therapeutics Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Microbiome Therapeutics Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
5 NORTH AMERICA AND EUROPE MARKET SEGMENTATION MICROBIOME THERAPEUTICS BY TYPE
5.1 North America and Europe Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
6 NORTH AMERICA AND EUROPE MARKET SEGMENTATION MICROBIOME THERAPEUTICS BY APPLICATION
6.1 North America and Europe Microbiome Therapeutics Sales Market Share by Application (2013-2018)
6.2 C. difficile Infection (CDI) Sales Growth (2013-2018)
6.3 Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
6.4 Orphan Drug Sales Growth (2013-2018)
6.5 Immuno-oncology Sales Growth (2013-2018)
6.6 Others Sales Growth (2013-2018)
7 UNITED STATES MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
7.1 United States Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
7.2.1 United States Microbiome Therapeutics Sales by Type (2013-2018)
7.2.2 United States Microbiome Therapeutics Sales Market Share by Type (2013-2018)
7.3 United States Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
7.3.1 United States Microbiome Therapeutics Sales by Application (2013-2018)
7.3.2 United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
7.4 United States Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Microbiome Therapeutics Export and Import (2013-2018)
8 UNITED KINGDOM MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
8.1 United Kingdom Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Microbiome Therapeutics Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Microbiome Therapeutics Sales by Type (2013-2018)
8.2.2 United Kingdom Microbiome Therapeutics Sales Market Share by Type (2013-2018)
8.3 United Kingdom Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Microbiome Therapeutics Sales by Application (2013-2018)
8.3.2 United Kingdom Microbiome Therapeutics Sales Market Share by Application (2013-2018)
8.4 United Kingdom Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Microbiome Therapeutics Export and Import (2013-2018)
9 CANADA MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
9.1 Canada Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
9.2.1 Canada Microbiome Therapeutics Sales by Type (2013-2018)
9.2.2 Canada Microbiome Therapeutics Sales Market Share by Type (2013-2018)
9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"
9.3.1 Canada Microbiome Therapeutics Sales by Application (2013-2018)
9.3.2 Canada Microbiome Therapeutics Sales Market Share by Application (2013-2018)
9.4 Canada Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Microbiome Therapeutics Export and Import (2013-2018)
10 GERMANY MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
10.1 Germany Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
10.2.1 Germany Microbiome Therapeutics Sales by Type (2013-2018)
10.2.2 Germany Microbiome Therapeutics Sales Market Share by Type (2013-2018)
10.3 Germany Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
10.3.1 Germany Microbiome Therapeutics Sales by Application (2013-2018)
10.3.2 Germany Microbiome Therapeutics Sales Market Share by Application (2013-2018)
10.4 Germany Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Microbiome Therapeutics Export and Import (2013-2018)
11 FRANCE MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
11.1 France Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
11.2 France Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
11.2.1 France Microbiome Therapeutics Sales by Type (2013-2018)
11.2.2 France Microbiome Therapeutics Sales Market Share by Type (2013-2018)
11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"
11.3.1 France Microbiome Therapeutics Sales by Application (2013-2018)
11.3.2 France Microbiome Therapeutics Sales Market Share by Application (2013-2018)
11.4 France Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Microbiome Therapeutics Revenue and Market Share by Manufacturer
11.5 France Microbiome Therapeutics Export and Import (2013-2018)
12 ITALY MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
12.1 Italy Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
12.2.1 Italy Microbiome Therapeutics Sales by Type (2013-2018)
12.2.2 Italy Microbiome Therapeutics Sales Market Share by Type (2013-2018)
12.3 Italy Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
12.3.1 Italy Microbiome Therapeutics Sales by Application (2013-2018)
12.3.2 Italy Microbiome Therapeutics Sales Market Share by Application (2013-2018)
12.4 Italy Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Microbiome Therapeutics Export and Import (2013-2018)
13 SPAIN MICROBIOME THERAPEUTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS
13.1 Spain Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
13.2.1 Spain Microbiome Therapeutics Sales by Type (2013-2018)
13.2.2 Spain Microbiome Therapeutics Sales Market Share by Type (2013-2018)
13.3 Spain Microbiome Therapeutics Sales by Application (2013-2018)
13.3.1 Spain Microbiome Therapeutics Sales by Application (2013-2018)
13.3.2 Spain Microbiome Therapeutics Sales Market Share by Application (2013-2018)
13.4 Spain Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Microbiome Therapeutics Export and Import (2013-2018)
14 MICROBIOME THERAPEUTICS MARKET FORECAST (2018-2023)
14.1 North America and Europe Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
14.2 Microbiome Therapeutics Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
14.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Microbiome Therapeutics Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
14.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Microbiome Therapeutics Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
15 MICROBIOME THERAPEUTICS MANUFACTURING COST ANALYSIS
15.1 Microbiome Therapeutics Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Microbiome Therapeutics
16 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
16.1 Microbiome Therapeutics Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
16.4 Downstream Buyers
17 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 RESEARCH FINDINGS AND CONCLUSION
19 APPENDIX
19.1 Methodology
19.2 Data Source
LIST OF TABLES AND FIGURES
Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure North America and Europe Sales Market Share of Microbiome Therapeutics by Types in 2017
Table Types of Microbiome Therapeutics
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Applications in 2017
Table Applications of Microbiome Therapeutics
Figure C. difficile Infection (CDI) Picture
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure United Kingdom Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Germany Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure France Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Italy Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Spain Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Microbiome Therapeutics Type and Applications
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table Assembly Biosciences Microbiome Therapeutics Type and Applications
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics Microbiome Therapeutics Type and Applications
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Interxon Basic Information, Manufacturing Base and Competitors
Table Interxon Microbiome Therapeutics Type and Applications
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PureTech Basic Information, Manufacturing Base and Competitors
Table PureTech Microbiome Therapeutics Type and Applications
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synlogic Basic Information, Manufacturing Base and Competitors
Table Synlogic Microbiome Therapeutics Type and Applications
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table Enterome BioScience Microbiome Therapeutics Type and Applications
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table 4D Pharma Basic Information, Manufacturing Base and Competitors
Table 4D Pharma Microbiome Therapeutics Type and Applications
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Second Genome Basic Information, Manufacturing Base and Competitors
Table Second Genome Microbiome Therapeutics Type and Applications
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AOBiome Basic Information, Manufacturing Base and Competitors
Table AOBiome Microbiome Therapeutics Type and Applications
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C3 Jian Basic Information, Manufacturing Base and Competitors
Table C3 Jian Microbiome Therapeutics Type and Applications
Table C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Microbiome Therapeutics Type and Applications
Table Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Type and Applications
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabiomics Basic Information, Manufacturing Base and Competitors
Table Metabiomics Microbiome Therapeutics Type and Applications
Table Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ritter Pharmaceuticals Microbiome Therapeutics Type and Applications
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symberix Basic Information, Manufacturing Base and Competitors
Table Symberix Microbiome Therapeutics Type and Applications
Table Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OpenBiome Basic Information, Manufacturing Base and Competitors
Table OpenBiome Microbiome Therapeutics Type and Applications
Table OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Azitra Basic Information, Manufacturing Base and Competitors
Table Azitra Microbiome Therapeutics Type and Applications
Table Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symbiotix Biotherapies Basic Information, Manufacturing Base and Competitors
Table Symbiotix Biotherapies Microbiome Therapeutics Type and Applications
Table Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Osel Basic Information, Manufacturing Base and Competitors
Table Osel Microbiome Therapeutics Type and Applications
Table Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabogen Basic Information, Manufacturing Base and Competitors
Table Metabogen Microbiome Therapeutics Type and Applications
Table Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America and Europe Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table North America and Europe Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Table North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
Figure North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America and Europe Microbiome Therapeutics Price by Manufacturers (2016-2017)
Figure Top 3 Microbiome Therapeutics Manufacturer Market Share in 2016
Figure Top 3 Microbiome Therapeutics Manufacturer Market Share in 2017
Figure Top 5 Microbiome Therapeutics Manufacturer Market Share in 2016
Figure Top 5 Microbiome Therapeutics Manufacturer Market Share in 2017
Figure North America and Europe Microbiome Therapeutics Sales and Growth (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales by Countries/Regions (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Countries in 2013
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Countries in 2017
Figure North America and Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table North America and Europe Microbiome Therapeutics Revenue by Countries (2013-2018)
Table North America and Europe Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America and Europe Microbiome Therapeutics Revenue Market Share by Countries in 2013
Figure North America and Europe Microbiome Therapeutics Revenue Market Share by Countries in 2017
Table North America and Europe Microbiome Therapeutics Sales by Type (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales Share by Type (2013-2018)
Table North America and Europe Microbiome Therapeutics Revenue by Type (2013-2018)
Table North America and Europe Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales by Application (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales Share by Application (2013-2018)
Figure North America and Europe C. difficile Infection (CDI) Sales Growth (2013-2018)
Figure North America and Europe Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
Figure North America and Europe Orphan Drug Sales Growth (2013-2018)
Figure North America and Europe Immuno-oncology Sales Growth (2013-2018)
Figure North America and Europe Others Sales Growth (2013-2018)
Figure United States Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table United States Microbiome Therapeutics Sales by Type (2013-2018)
Table United States Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table United States Microbiome Therapeutics Sales by Application (2013-2018)
Table United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table United States Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure United States Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure United States Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table United States Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure United States Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure United States Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table United States Microbiome Therapeutics Export and Import (2013-2018)
Figure United Kingdom Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure United Kingdom Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales by Type (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales by Application (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure United Kingdom Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure United Kingdom Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table United Kingdom Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure United Kingdom Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure United Kingdom Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table United Kingdom Microbiome Therapeutics Export and Import (2013-2018)
Figure Canada Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Canada Microbiome Therapeutics Sales by Type (2013-2018)
Table Canada Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Canada Microbiome Therapeutics Sales by Application (2013-2018)
Table Canada Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Canada Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Canada Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Canada Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Canada Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Canada Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Canada Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Canada Microbiome Therapeutics Export and Import (2013-2018)
Figure Germany Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Germany Microbiome Therapeutics Sales by Type (2013-2018)
Table Germany Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Germany Microbiome Therapeutics Sales by Application (2013-2018)
Table Germany Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Germany Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Germany Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Germany Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Germany Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Germany Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Germany Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Germany Microbiome Therapeutics Export and Import (2013-2018)
Figure France Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table France Microbiome Therapeutics Sales by Type (2013-2018)
Table France Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table France Microbiome Therapeutics Sales by Application (2013-2018)
Table France Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table France Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure France Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure France Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table France Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure France Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure France Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table France Microbiome Therapeutics Export and Import (2013-2018)
Figure Italy Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Italy Microbiome Therapeutics Sales by Type (2013-2018)
Table Italy Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Italy Microbiome Therapeutics Sales by Application (2013-2018)
Table Italy Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Italy Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Italy Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Italy Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Italy Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Italy Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Italy Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Italy Microbiome Therapeutics Export and Import (2013-2018)
Figure Spain Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Spain Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Spain Microbiome Therapeutics Sales by Type (2013-2018)
Table Spain Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Spain Microbiome Therapeutics Sales by Application (2013-2018)
Table Spain Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Spain Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Spain Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Spain Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Spain Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Spain Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Spain Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Spain Microbiome Therapeutics Export and Import (2013-2018)
Figure North America and Europe Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table North America and Europe Microbiome Therapeutics Sales Forecast by Countries/Regions (2018-2023)
Table North America and Europe Microbiome Therapeutics Market Share Forecast by Countries/Regions (2018-2023)
Figure United States Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure United Kingdom Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure Canada Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure Germany Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure France Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure Italy Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure Spain Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Table North America and Europe Microbiome Therapeutics Sales Forecast by Type (2018-2023)
Table North America and Europe Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
Table North America and Europe Microbiome Therapeutics Sales Forecast by Application (2018-2023)
Table North America and Europe Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microbiome Therapeutics
Figure Manufacturing Process Analysis of Microbiome Therapeutics
Figure Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
Table Major Buyers of Microbiome Therapeutics
Table Distributors/Traders/ Dealers List
Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure North America and Europe Sales Market Share of Microbiome Therapeutics by Types in 2017
Table Types of Microbiome Therapeutics
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Applications in 2017
Table Applications of Microbiome Therapeutics
Figure C. difficile Infection (CDI) Picture
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure United Kingdom Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Germany Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure France Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Italy Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Spain Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Microbiome Therapeutics Type and Applications
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table Assembly Biosciences Microbiome Therapeutics Type and Applications
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics Microbiome Therapeutics Type and Applications
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Interxon Basic Information, Manufacturing Base and Competitors
Table Interxon Microbiome Therapeutics Type and Applications
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PureTech Basic Information, Manufacturing Base and Competitors
Table PureTech Microbiome Therapeutics Type and Applications
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synlogic Basic Information, Manufacturing Base and Competitors
Table Synlogic Microbiome Therapeutics Type and Applications
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table Enterome BioScience Microbiome Therapeutics Type and Applications
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table 4D Pharma Basic Information, Manufacturing Base and Competitors
Table 4D Pharma Microbiome Therapeutics Type and Applications
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Second Genome Basic Information, Manufacturing Base and Competitors
Table Second Genome Microbiome Therapeutics Type and Applications
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AOBiome Basic Information, Manufacturing Base and Competitors
Table AOBiome Microbiome Therapeutics Type and Applications
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C3 Jian Basic Information, Manufacturing Base and Competitors
Table C3 Jian Microbiome Therapeutics Type and Applications
Table C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Microbiome Therapeutics Type and Applications
Table Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Type and Applications
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabiomics Basic Information, Manufacturing Base and Competitors
Table Metabiomics Microbiome Therapeutics Type and Applications
Table Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ritter Pharmaceuticals Microbiome Therapeutics Type and Applications
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symberix Basic Information, Manufacturing Base and Competitors
Table Symberix Microbiome Therapeutics Type and Applications
Table Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OpenBiome Basic Information, Manufacturing Base and Competitors
Table OpenBiome Microbiome Therapeutics Type and Applications
Table OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Azitra Basic Information, Manufacturing Base and Competitors
Table Azitra Microbiome Therapeutics Type and Applications
Table Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symbiotix Biotherapies Basic Information, Manufacturing Base and Competitors
Table Symbiotix Biotherapies Microbiome Therapeutics Type and Applications
Table Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Osel Basic Information, Manufacturing Base and Competitors
Table Osel Microbiome Therapeutics Type and Applications
Table Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabogen Basic Information, Manufacturing Base and Competitors
Table Metabogen Microbiome Therapeutics Type and Applications
Table Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America and Europe Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table North America and Europe Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Table North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
Figure North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America and Europe Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America and Europe Microbiome Therapeutics Price by Manufacturers (2016-2017)
Figure Top 3 Microbiome Therapeutics Manufacturer Market Share in 2016
Figure Top 3 Microbiome Therapeutics Manufacturer Market Share in 2017
Figure Top 5 Microbiome Therapeutics Manufacturer Market Share in 2016
Figure Top 5 Microbiome Therapeutics Manufacturer Market Share in 2017
Figure North America and Europe Microbiome Therapeutics Sales and Growth (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales by Countries/Regions (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Countries in 2013
Figure North America and Europe Microbiome Therapeutics Sales Market Share by Countries in 2017
Figure North America and Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table North America and Europe Microbiome Therapeutics Revenue by Countries (2013-2018)
Table North America and Europe Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America and Europe Microbiome Therapeutics Revenue Market Share by Countries in 2013
Figure North America and Europe Microbiome Therapeutics Revenue Market Share by Countries in 2017
Table North America and Europe Microbiome Therapeutics Sales by Type (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales Share by Type (2013-2018)
Table North America and Europe Microbiome Therapeutics Revenue by Type (2013-2018)
Table North America and Europe Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales by Application (2013-2018)
Table North America and Europe Microbiome Therapeutics Sales Share by Application (2013-2018)
Figure North America and Europe C. difficile Infection (CDI) Sales Growth (2013-2018)
Figure North America and Europe Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
Figure North America and Europe Orphan Drug Sales Growth (2013-2018)
Figure North America and Europe Immuno-oncology Sales Growth (2013-2018)
Figure North America and Europe Others Sales Growth (2013-2018)
Figure United States Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table United States Microbiome Therapeutics Sales by Type (2013-2018)
Table United States Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table United States Microbiome Therapeutics Sales by Application (2013-2018)
Table United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table United States Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure United States Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure United States Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table United States Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure United States Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure United States Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table United States Microbiome Therapeutics Export and Import (2013-2018)
Figure United Kingdom Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure United Kingdom Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales by Type (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales by Application (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table United Kingdom Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure United Kingdom Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure United Kingdom Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table United Kingdom Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure United Kingdom Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure United Kingdom Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table United Kingdom Microbiome Therapeutics Export and Import (2013-2018)
Figure Canada Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Canada Microbiome Therapeutics Sales by Type (2013-2018)
Table Canada Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Canada Microbiome Therapeutics Sales by Application (2013-2018)
Table Canada Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Canada Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Canada Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Canada Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Canada Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Canada Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Canada Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Canada Microbiome Therapeutics Export and Import (2013-2018)
Figure Germany Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Germany Microbiome Therapeutics Sales by Type (2013-2018)
Table Germany Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Germany Microbiome Therapeutics Sales by Application (2013-2018)
Table Germany Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Germany Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Germany Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Germany Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Germany Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Germany Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Germany Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Germany Microbiome Therapeutics Export and Import (2013-2018)
Figure France Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table France Microbiome Therapeutics Sales by Type (2013-2018)
Table France Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table France Microbiome Therapeutics Sales by Application (2013-2018)
Table France Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table France Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure France Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure France Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table France Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure France Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure France Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table France Microbiome Therapeutics Export and Import (2013-2018)
Figure Italy Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Italy Microbiome Therapeutics Sales by Type (2013-2018)
Table Italy Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Italy Microbiome Therapeutics Sales by Application (2013-2018)
Table Italy Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Italy Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Italy Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Italy Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Italy Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Italy Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Italy Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Italy Microbiome Therapeutics Export and Import (2013-2018)
Figure Spain Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Spain Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Spain Microbiome Therapeutics Sales by Type (2013-2018)
Table Spain Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Spain Microbiome Therapeutics Sales by Application (2013-2018)
Table Spain Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Spain Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Spain Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Spain Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Spain Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Spain Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Spain Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Spain Microbiome Therapeutics Export and Import (2013-2018)
Figure North America and Europe Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table North America and Europe Microbiome Therapeutics Sales Forecast by Countries/Regions (2018-2023)
Table North America and Europe Microbiome Therapeutics Market Share Forecast by Countries/Regions (2018-2023)
Figure United States Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure United Kingdom Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure Canada Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure Germany Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure France Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure Italy Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Figure Spain Microbiome Therapeutics Sales and Growth Rate Forecast (2018-2023)
Table North America and Europe Microbiome Therapeutics Sales Forecast by Type (2018-2023)
Table North America and Europe Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
Table North America and Europe Microbiome Therapeutics Sales Forecast by Application (2018-2023)
Table North America and Europe Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microbiome Therapeutics
Figure Manufacturing Process Analysis of Microbiome Therapeutics
Figure Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
Table Major Buyers of Microbiome Therapeutics
Table Distributors/Traders/ Dealers List
